Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
PHASE3
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
PHASE1
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
PHASE1
This phase I trial studies the side effects and best dose of genetically mo...
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant
PHASE3
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study
PHASE1
The goal of this study is to evaluate the safety of melphalan and autologou...
High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas
PHASE3
RATIONALE: Drugs used in chemotherapy, such as carboplatin, thiotepa, and e...
Status
Completed
Location
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences